Copyright Reports & Markets. All rights reserved.

Global G-CSF and G-CSF Biosimilars Market Research Report 2021

Request for Sample of this report
Buy now

1 G-CSF and G-CSF Biosimilars Market Overview

  • 1.1 Product Overview and Scope of G-CSF and G-CSF Biosimilars
  • 1.2 G-CSF and G-CSF Biosimilars Segment by Type
    • 1.2.1 Global G-CSF and G-CSF Biosimilars Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Blood Disorders
    • 1.2.3 Oncology Diseases
    • 1.2.4 Chronic And Autoimmune Diseases
    • 1.2.5 Growth Hormone Deficiencies
  • 1.3 G-CSF and G-CSF Biosimilars Segment by Application
    • 1.3.1 G-CSF and G-CSF Biosimilars Sales Comparison by Application: (2021-2027)
    • 1.3.2 Human Growth Hormone
    • 1.3.3 Erythropoietin
    • 1.3.4 Monoclonal Antibodies
    • 1.3.5 Insulin
    • 1.3.6 Interferon
  • 1.4 Global G-CSF and G-CSF Biosimilars Market Size Estimates and Forecasts
    • 1.4.1 Global G-CSF and G-CSF Biosimilars Revenue 2016-2027
    • 1.4.2 Global G-CSF and G-CSF Biosimilars Sales 2016-2027
    • 1.4.3 G-CSF and G-CSF Biosimilars Market Size by Region: 2016 Versus 2021 Versus 2027

2 G-CSF and G-CSF Biosimilars Market Competition by Manufacturers

  • 2.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global G-CSF and G-CSF Biosimilars Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers G-CSF and G-CSF Biosimilars Manufacturing Sites, Area Served, Product Type
  • 2.5 G-CSF and G-CSF Biosimilars Market Competitive Situation and Trends
    • 2.5.1 G-CSF and G-CSF Biosimilars Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest G-CSF and G-CSF Biosimilars Players Market Share by Revenue
    • 2.5.3 Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 G-CSF and G-CSF Biosimilars Retrospective Market Scenario by Region

  • 3.1 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
    • 3.3.1 North America G-CSF and G-CSF Biosimilars Sales by Country
    • 3.3.2 North America G-CSF and G-CSF Biosimilars Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
    • 3.4.1 Europe G-CSF and G-CSF Biosimilars Sales by Country
    • 3.4.2 Europe G-CSF and G-CSF Biosimilars Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific G-CSF and G-CSF Biosimilars Market Facts & Figures by Region
    • 3.5.1 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region
    • 3.5.2 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
    • 3.6.1 Latin America G-CSF and G-CSF Biosimilars Sales by Country
    • 3.6.2 Latin America G-CSF and G-CSF Biosimilars Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country
    • 3.7.2 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global G-CSF and G-CSF Biosimilars Historic Market Analysis by Type

  • 4.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2016-2021)
  • 4.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2016-2021)
  • 4.3 Global G-CSF and G-CSF Biosimilars Price by Type (2016-2021)

5 Global G-CSF and G-CSF Biosimilars Historic Market Analysis by Application

  • 5.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2016-2021)
  • 5.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2016-2021)
  • 5.3 Global G-CSF and G-CSF Biosimilars Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Pfizer
    • 6.1.1 Pfizer Corporation Information
    • 6.1.2 Pfizer Description and Business Overview
    • 6.1.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Pfizer Product Portfolio
    • 6.1.5 Pfizer Recent Developments/Updates
  • 6.2 Novartis
    • 6.2.1 Novartis Corporation Information
    • 6.2.2 Novartis Description and Business Overview
    • 6.2.3 Novartis G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Novartis Product Portfolio
    • 6.2.5 Novartis Recent Developments/Updates
  • 6.3 Roche
    • 6.3.1 Roche Corporation Information
    • 6.3.2 Roche Description and Business Overview
    • 6.3.3 Roche G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Roche Product Portfolio
    • 6.3.5 Roche Recent Developments/Updates
  • 6.4 Merck & Co.
    • 6.4.1 Merck & Co. Corporation Information
    • 6.4.2 Merck & Co. Description and Business Overview
    • 6.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Merck & Co. Product Portfolio
    • 6.4.5 Merck & Co. Recent Developments/Updates
  • 6.5 Sanofi
    • 6.5.1 Sanofi Corporation Information
    • 6.5.2 Sanofi Description and Business Overview
    • 6.5.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Sanofi Product Portfolio
    • 6.5.5 Sanofi Recent Developments/Updates
  • 6.6 Johnson & Johnson
    • 6.6.1 Johnson & Johnson Corporation Information
    • 6.6.2 Johnson & Johnson Description and Business Overview
    • 6.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Johnson & Johnson Product Portfolio
    • 6.6.5 Johnson & Johnson Recent Developments/Updates
  • 6.7 Gilead Science
    • 6.6.1 Gilead Science Corporation Information
    • 6.6.2 Gilead Science Description and Business Overview
    • 6.6.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Gilead Science Product Portfolio
    • 6.7.5 Gilead Science Recent Developments/Updates
  • 6.8 GlaxoSmithKline
    • 6.8.1 GlaxoSmithKline Corporation Information
    • 6.8.2 GlaxoSmithKline Description and Business Overview
    • 6.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 GlaxoSmithKline Product Portfolio
    • 6.8.5 GlaxoSmithKline Recent Developments/Updates
  • 6.9 AbbVie
    • 6.9.1 AbbVie Corporation Information
    • 6.9.2 AbbVie Description and Business Overview
    • 6.9.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 AbbVie Product Portfolio
    • 6.9.5 AbbVie Recent Developments/Updates
  • 6.10 Amgen
    • 6.10.1 Amgen Corporation Information
    • 6.10.2 Amgen Description and Business Overview
    • 6.10.3 Amgen G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Amgen Product Portfolio
    • 6.10.5 Amgen Recent Developments/Updates
  • 6.11 AstraZeneca
    • 6.11.1 AstraZeneca Corporation Information
    • 6.11.2 AstraZeneca G-CSF and G-CSF Biosimilars Description and Business Overview
    • 6.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 AstraZeneca Product Portfolio
    • 6.11.5 AstraZeneca Recent Developments/Updates
  • 6.12 Bayer
    • 6.12.1 Bayer Corporation Information
    • 6.12.2 Bayer G-CSF and G-CSF Biosimilars Description and Business Overview
    • 6.12.3 Bayer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Bayer Product Portfolio
    • 6.12.5 Bayer Recent Developments/Updates

7 G-CSF and G-CSF Biosimilars Manufacturing Cost Analysis

  • 7.1 G-CSF and G-CSF Biosimilars Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of G-CSF and G-CSF Biosimilars
  • 7.4 G-CSF and G-CSF Biosimilars Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 G-CSF and G-CSF Biosimilars Distributors List
  • 8.3 G-CSF and G-CSF Biosimilars Customers

9 G-CSF and G-CSF Biosimilars Market Dynamics

  • 9.1 G-CSF and G-CSF Biosimilars Industry Trends
  • 9.2 G-CSF and G-CSF Biosimilars Growth Drivers
  • 9.3 G-CSF and G-CSF Biosimilars Market Challenges
  • 9.4 G-CSF and G-CSF Biosimilars Market Restraints

10 Global Market Forecast

  • 10.1 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of G-CSF and G-CSF Biosimilars by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of G-CSF and G-CSF Biosimilars by Type (2022-2027)
  • 10.2 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of G-CSF and G-CSF Biosimilars by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of G-CSF and G-CSF Biosimilars by Application (2022-2027)
  • 10.3 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of G-CSF and G-CSF Biosimilars by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of G-CSF and G-CSF Biosimilars by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Blood Disorders
    Oncology Diseases
    Chronic And Autoimmune Diseases
    Growth Hormone Deficiencies

    Segment by Application
    Human Growth Hormone
    Erythropoietin
    Monoclonal Antibodies
    Insulin
    Interferon

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Pfizer
    Novartis
    Roche
    Merck & Co.
    Sanofi
    Johnson & Johnson
    Gilead Science
    GlaxoSmithKline
    AbbVie
    Amgen
    AstraZeneca
    Bayer

    Buy now